PHARMAC funds new treatments for breast and blood cancer

27 March 2024 - PHARMAC is funding two new cancer treatments, one for advanced breast cancer (ribociclib succinate) and one ...

Read more →

Busy dad with leukaemia getting 'outdated treatment'

23 February 2024 - A West Coast dad is receiving “outdated treatment” for his leukaemia because PHARMAC’s policies are blocking ...

Read more →

A cancer doctor’s view of why reform of PHARMAC is vital

23 February 2024 - Late last year, many of my colleagues returned from the largest international gathering of doctors who ...

Read more →

PHARMAC to fund new treatments for breast and blood cancer

14 February 2024 - PHARMAC is funding two new cancer treatments, for advanced breast cancer, and for blood cancer, which will ...

Read more →

Desperate PHARMAC plea from family selling cans for unfunded myeloma cancer drugs

11 February 2024 - Multiple myeloma, a common blood cancer, is incurable, but can be survived for years with the right ...

Read more →

Father of two has to get cancer treatment in Germany after PHARMAC complications

21 December 2023 - An Auckland man has resorted to treatment for an aggressive bone marrow cancer in Germany after ...

Read more →

PHARMAC proposes to fund treatments for breast and blood cancer

12 December 2023 - PHARMAC is seeking feedback on a proposal to fund two new treatments for advanced breast cancer and ...

Read more →

New Zealand Pharmaceutical Schedule - 1 December 2023

1 December 2023 - The December 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Treatment options for people with glioma, a type of brain cancer

13 September 2023 - BMS, the supplier of lomustine, a treatment used for a type of brain cancer called glioma, is ...

Read more →

Oncologists pen open letter to PHARMAC asking for more life-saving cancer drugs

5 September 2023 - Drug buying agency PHARMAC is not moving fast enough, says a gut cancer patient paying more ...

Read more →

PHARMAC announcement of more blood cancer medicines welcomed

27 August 2023 - Myeloma New Zealand is welcoming Pharmac's announcement of more blood cancer medicines, but says the country is ...

Read more →

PHARMAC seeking bids from suppliers for multiple myeloma treatments

24 August 2023 - PHARMAC is seeking bids from suppliers for two medicines, lenalidomide and pomalidomide, for use in the ...

Read more →

Suggestions Nat's cancer drug funding promise has put PHARMAC in a difficult position

22 August 2023 - It's being suggested National's cancer drug funding promise has put PHARMAC in a difficult position. ...

Read more →

National to roll back free prescription fees to pay for 13 cancer treatments

21 August 2023 - The National Party wants to bring back the $5 prescription fee for those who can afford ...

Read more →

PHARMAC proposes widening access to a brain cancer treatment to help reduce the impact of a discontinuation

11 August 2023 - PHARMAC is proposing to widen access to temozolomide, an oral anti-cancer treatment, for people with a type ...

Read more →